---
figid: PMC5123561__nihms831274f3
figtitle: 'Heterotrimeric G Proteins: Breaking the rules of engagement, space and
  time'
organisms:
- NA
pmcid: PMC5123561
filename: nihms831274f3.jpg
figlink: /pmc/articles/PMC5123561/figure/F3/
number: F3
caption: Upper parts of the schematic shows multiple classes of receptors, some that
  sense a variety of chemical stimuli and others that sense mechanical signals, all
  of which utilize GIV-GEF to transactivate G proteins. The solid arrow connecting
  RTKs and GIV indicates that the mechanism for such engagement is well understood.
  The broken arrows linking all other receptors and GIV indicate that little or nothing
  is known as to how GIV may engage with those receptors. Lower part of the schematic
  shows the consequence of such activation (when GIV-GEF is turned "ON") on diverse
  signaling pathway within the signaling network. Green = enhancement; Red = suppression.
  This profile of signaling is reversed when GIV-GEF is switched "OFF", i.e., enhanced
  signals are suppressed and vice versa. Shown in the middle are three known ways
  to inhibit GIV-dependent signaling (PKCθ selectively phosphoinhibits GIV-GEF[];
  SHP-1 dephosphorylates tyrosine-phosphorylated GIV []) or activate (CDK5 phosphoactivates
  GIV-GEF []).
papertitle: 'Heterotrimeric G Proteins: Breaking the rules of engagement, space and
  time.'
reftext: Krishna K. Midde, et al. Bioessays. ;38(4):379-393.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9607422
figid_alias: PMC5123561__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5123561__F3
ndex: 22690b09-dea9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5123561__nihms831274f3.html
  '@type': Dataset
  description: Upper parts of the schematic shows multiple classes of receptors, some
    that sense a variety of chemical stimuli and others that sense mechanical signals,
    all of which utilize GIV-GEF to transactivate G proteins. The solid arrow connecting
    RTKs and GIV indicates that the mechanism for such engagement is well understood.
    The broken arrows linking all other receptors and GIV indicate that little or
    nothing is known as to how GIV may engage with those receptors. Lower part of
    the schematic shows the consequence of such activation (when GIV-GEF is turned
    "ON") on diverse signaling pathway within the signaling network. Green = enhancement;
    Red = suppression. This profile of signaling is reversed when GIV-GEF is switched
    "OFF", i.e., enhanced signals are suppressed and vice versa. Shown in the middle
    are three known ways to inhibit GIV-dependent signaling (PKCθ selectively phosphoinhibits
    GIV-GEF[]; SHP-1 dephosphorylates tyrosine-phosphorylated GIV []) or activate
    (CDK5 phosphoactivates GIV-GEF []).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - TLR4
  - INSR
  - IGF1R
  - INSRR
  - MS4A2
  - PHF11
  - EGFR
  - PDGFRB
  - PDGFRA
  - KDR
  - FLT1
  - FLT4
  - LPAR1
  - LPAR2
  - LPAR3
  - FZD4
  - NMUR1
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - BSG
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - SRC
  - FGR
  - FYN
  - YES1
  - PTK2
  - CCDC88A
  - PTPN6
  - CDK5
  - F2RL2
  - PARD3
  - SMAD2
  - STAT3
  - PLCG1
  - PTPN11
  - STAT5A
  - STAT5B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - AKT1
  - AKT2
  - AKT3
  - MMP2
  - BCL2
  - MMP9
  - FOXO1
  - MTOR
  - Ser
  - Thr
  - Cancer
---
